Zoetis (ZTS) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $1.87
- Estimate
- $1.85
- Surprise
- +0.9%
- Revenue (period 2026-06-30)
- $2.47B
- Score at report (before → after)
- 6.2 → 6.2/10
Revenue source: xbrl.
How the report landed
Zoetis (ZTS) beat the $1.85 estimate with diluted EPS of $1.87 — a modest 0.9% upside surprise. TrendMatrix's engine moved from Buy (Wait) (6.2/10) to Sell at 6.2/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates ZTS Sell at 5.5/10.
3 of the last 4 quarters beat the estimate; this quarter's +0.9% surprise compares with a +1.5% four-quarter average. Next scheduled report: 2026-11-03.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.2 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Concentration risk — Geographic: United States (54.0%)
- Concentration risk — Product: companion animal products (70.0%)
- Leverage penalty (D/E 2.9): -1.5
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $76.30
- Price target
- $86.40
- Stop
- $71.53
- Upside to target
- +13.2%
- Reward-to-risk
- 1.9:1
At 12.4× trailing and 11.7× forward earnings, consensus estimates imply little change in earnings power.
Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.
ZTS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - Specialty & Generic
- Market cap
- $31.52B
- P/E (fwd)
- 11.7
- P/E (ttm)
- 12.4
- 52-week range
- $71.00–$155.15
- Off 52-week high
- 50.8%
- RSI (14)
- 58
- Volume vs avg
- 0.57×
- Score today
- 5.5/10